Just listened to the webinar....really good information on Retts....one of two doctors talked about Retts disease characteristics (including seizures) and the second doctor talked about observations from the A-273 trial....she was more than excited and said "this could be a boon for neurological diseases (including Fragile X) and that because she is aging, she would like to be able to take the A-273 drug as well!
Hold on to those shares longs!!!
(1)
(0)
Anavex Life Sciences Corp. (AVXL) Stock Research Links